Atom Investors LP Alkermes Plc. Transaction History

Atom Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $1.3 Million - $1.75 Million	-69,388 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $11.6 Million - $14.8 Million	-638,080 Reduced 90.19%	69,388 $1.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $3.45 Million - $4.95 Million	223,902 Added 46.3%	707,468 $14.1 Million
Q3 2020 Nov 13, 2020	BUY	$16.16 - $20.66 $553,835 - $708,059	34,272 Added 7.63%	483,566 $8.01 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $19.41 $1.41 Million - $2.06 Million	106,035 Added 30.89%	449,294 $8.72 Million
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $4.48 Million - $7.29 Million	343,259 New	343,259 $4.95 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.